Pinnacle Associates LTD Ptc Therapeutics, Inc. Transaction History

Pinnacle Associates LTD

$6.3 Billion
Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Pinnacle Associates LTD holds 154,204 shares of PTCT stock, worth $6.05 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

154,204

Previous 153,904 0.19%

Holding current value

$6.05 Million

Previous $4.71 Million 21.55%

% of portfolio

0.09%

Previous 0.08%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$30.39 - $37.66 $9,117 - $11,297	300 Added 0.19%	154,204 $5.72 Million
Q2 2024 Jul 30, 2024	SELL	$24.69 - $40.12 $74,909 - $121,724	-3,034 Reduced 1.93%	153,904 $4.71 Million
Q1 2024 Apr 26, 2024	BUY	$24.15 - $31.95 $66,026 - $87,351	2,734 Added 1.77%	156,938 $4.57 Million
Q4 2023 Jan 19, 2024	SELL	$18.07 - $29.37 $53,740 - $87,346	-2,974 Reduced 1.89%	154,204 $4.25 Million
Q3 2023 Oct 23, 2023	SELL	$22.41 - $41.99 $152,881 - $286,455	-6,822 Reduced 4.16%	157,178 $3.52 Million
Q2 2023 Jul 26, 2023	SELL	$40.4 - $59.1 $245,793 - $359,564	-6,084 Reduced 3.58%	164,000 $6.67 Million
Q1 2023 May 04, 2023	SELL	$38.16 - $48.86 $96,125 - $123,078	-2,519 Reduced 1.46%	170,084 $8.24 Million
Q4 2022 Jan 31, 2023	SELL	$33.53 - $54.79 $63,036 - $103,005	-1,880 Reduced 1.08%	172,603 $6.59 Million
Q4 2022 Jan 25, 2023	SELL	$33.53 - $54.79 $121,210 - $198,065	-3,615 Reduced 2.03%	174,483 $0
Q3 2022 Oct 31, 2022	SELL	$41.85 - $53.85 $245,994 - $316,530	-5,878 Reduced 3.19%	178,098 $8.94 Million
Q2 2022 Aug 02, 2022	SELL	$25.6 - $45.23 $15,488 - $27,364	-605 Reduced 0.33%	183,976 $7.37 Million
Q1 2022 May 05, 2022	SELL	$33.33 - $44.6 $269,973 - $361,260	-8,100 Reduced 4.2%	184,581 $6.89 Million
Q4 2021 Feb 02, 2022	SELL	$35.36 - $41.86 $2,934 - $3,474	-83 Reduced 0.04%	192,681 $7.67 Million
Q3 2021 Oct 19, 2021	BUY	$37.01 - $44.74 $1.14 Million - $1.38 Million	30,930 Added 19.11%	192,764 $7.17 Million
Q2 2021 Aug 02, 2021	BUY	$37.95 - $49.37 $2.28 Million - $2.96 Million	60,014 Added 58.94%	161,834 $6.84 Million
Q1 2021 May 12, 2021	SELL	$46.8 - $68.92 $523,925 - $771,559	-11,195 Reduced 9.91%	101,820 $4.82 Million
Q4 2020 Jan 26, 2021	SELL	$47.96 - $67.64 $365,023 - $514,808	-7,611 Reduced 6.31%	113,015 $6.9 Million
Q3 2020 Oct 23, 2020	SELL	$45.41 - $57.07 $243,533 - $306,066	-5,363 Reduced 4.26%	120,626 $5.64 Million
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $105,336 - $136,075	-2,475 Reduced 1.93%	125,989 $6.39 Million
Q1 2020 May 13, 2020	SELL	$32.37 - $59.36 $674,072 - $1.24 Million	-20,824 Reduced 13.95%	128,464 $5.73 Million
Q4 2019 Feb 03, 2020	SELL	$32.22 - $50.07 $487,488 - $757,559	-15,130 Reduced 9.2%	149,288 $7.17 Million
Q3 2019 Nov 08, 2019	SELL	$33.82 - $48.17 $259,399 - $369,463	-7,670 Reduced 4.46%	164,418 $5.56 Million
Q2 2019 Aug 05, 2019	SELL	$35.42 - $45.0 $582,127 - $739,575	-16,435 Reduced 8.72%	172,088 $7.74 Million
Q1 2019 May 10, 2019	SELL	$28.09 - $39.49 $118,961 - $167,240	-4,235 Reduced 2.2%	188,523 $7.1 Million
Q4 2018 Feb 05, 2019	SELL	$29.83 - $46.51 $252,033 - $392,962	-8,449 Reduced 4.2%	192,758 $6.62 Million
Q3 2018 Nov 13, 2018	SELL	$33.9 - $47.77 $1.14 Million - $1.61 Million	-33,775 Reduced 14.37%	201,207 $9.46 Million
Q2 2018 Aug 08, 2018	SELL	$25.7 - $47.88 $1.09 Million - $2.03 Million	-42,380 Reduced 15.28%	234,982 $7.93 Million
Q1 2018 May 11, 2018	SELL	$17.46 - $32.59 $210,742 - $393,361	-12,070 Reduced 4.17%	277,362 $7.51 Million
Q4 2017 Feb 12, 2018	SELL	$15.14 - $20.89 $444,813 - $613,748	-29,380 Reduced 9.22%	289,432 $4.83 Million
Q3 2017 Nov 13, 2017	SELL	$16.81 - $21.61 $136,329 - $175,257	-8,110 Reduced 2.48%	318,812 $6.38 Million
Q2 2017 Aug 09, 2017	BUY	N/A	326,922	326,922 $5.99 Million

Others Institutions Holding PTCT

# of Institutions

223

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Ptc Therapeutics, Inc. Transaction History